The investigation of phenotypes in model organisms has the potential to reveal the molecular mechanisms underlying disease. The large-scale comparative analysis of phenotypes across species can reveal novel associations between genotypes and diseases. We use the PhenomeNET network of phenotypic similarity to suggest genotype-disease association, combine them with drug-gene associations available from the PharmGKB database, and infer novel associations between drugs and diseases. We evaluate and quantify our results based on our method's capability to reproduce known drug-disease associations. We find and discuss evidence that levonorgestrel, tretinoin and estradiol are associated with cystic fibrosis (p < 2.65 · 10 -6 , p < 0.002 and p < 0.031, Wilcoxon signedrank test, Bonferroni correction) and that ibuprofen may be active in chronic lymphocytic leukemia (p < 2.63 · 10 -23 , Wilcoxon signed-rank test, Bonferroni correction). To enable access to our results, we implement a web server and make our raw data freely available. Our results are the first steps in implementing an integrated system for the analysis and prediction of drug-disease associations for rare and orphan diseases for which the molecular basis is not known.
CITATION STYLE
Hoehndorf, R., Oellrich, A., Rebholz-Schuhmann, D., Schofield, P. N., & Gkoutos, G. V. (2012). Linking pharmgkb to phenotype studies and animal models of disease for drug repurposing. In Pacific Symposium on Biocomputing (pp. 388–399). https://doi.org/10.1142/9789814366496_0038
Mendeley helps you to discover research relevant for your work.